K M C Speciality Hospitals (India) peers

Companies like K M C Speciality Hospitals (India)latest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

KMCSHIL₹149.36

K M C Speciality Hospitals (India) Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMEDMcap ₹2,439 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
KMCSHIL
FY24
DRAGARWQ
FY26
KOVAI
FY20
LOTUSEYE
FY26
Peer
Average
Valuation — at last close
P/E80.30×◆ 36.05×68.21×2750.00×951.42× -92%
P/B—7.30×14.97×◆ 3.80×8.69×
EV/EBITDA—◆ 17.29×40.93×69.87×42.70×
Market Cap₹2,439 Cr₹2,527 Cr₹6,452 Cr₹229 Cr₹3,069 Cr -21%
Growth
Revenue CAGR 3Y19.96%◆ 20.68%—4.52%12.60% +58%
Revenue CAGR 5Y—◆ 22.59%—10.66%16.63%
Net Income CAGR 3Y◆ 33.46%23.83%—-72.98%-24.58% +236%
Revenue YoY (latest Q)———26.19%26.19%
Net Income YoY (latest Q)———12.65%12.65%
Profitability
EBITDA Margin26.75%◆ 30.86%23.61%6.30%20.26% +32%
Net Income Margin◆ 17.15%14.89%13.29%0.15%9.44% +82%
Return on Common Equity—◆ 25.22%21.94%0.13%15.76%
Return on Capital Employed—◆ 16.87%10.47%-0.54%8.93%
Return on Assets—◆ 10.16%8.54%0.11%6.27%
Credit & Quality
Total Debt/Equity—0.24×1.18×◆ 0.19×0.54×
Interest Coverage◆ 32.79×8.39×7.93×-0.43×5.30× +519%
Scale — latest FY
Revenue / Total Income₹177 Cr₹471 Cr₹712 Cr₹53.7 Cr₹412 Cr -57%
Net Income₹30.4 Cr₹70.1 Cr₹94.6 Cr₹0.1 Cr₹54.9 Cr -45%
Total Assets—₹766 Cr₹1,107 Cr₹82.6 Cr₹652 Cr
EPS₹1.86₹147.02₹86.44₹0.04₹77.83 -98%
Book Value per Share—₹726.29₹393.91₹28.92₹383.04
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.